Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Analysis

Editor-in-Chief

ISSN (Print): 1573-4129
ISSN (Online): 1875-676X

Back
Research Article

Analysis of the Genotoxic Impurity S-(+)-Epichlorohydrin Contained in (S)-Oxiracetam using Gas Chromatography

Author(s): Jinbiao Li, Dandan Li, Wenjing Lu, Jinhui Wu* and Hong Dong*

Volume 18, Issue 6, 2022

Published on: 26 April, 2022

Page: [642 - 649] Pages: 8

DOI: 10.2174/1573412918666220128092202

Price: $65

Abstract

Background: (S)-oxiracetam has shown better efficacy than racemic oxiracetam in the trial. However, there is no report on the method used to detect the genotoxic impurity of S-(+)- epichlorohydrin(S-(+)-ECH) that may be contained in (S)-oxiracetam.

Objective: Here, we have proposed and verified a detailed analysis method for the (S-(+)-ECH) impurity in (S)-oxiracetam using a gas chromatography(GC) system.

Methods: The chromatography system includes a Supelco DB-624 capillary column. The initial column temperature was 50°C, kept for 4 minutes, and then increased to 220°C at a rate of 10°C/min for 4 minutes. Nitrogen was used as the carrier gas. The constant flow rate was 3.8 mL/min, the split ratio was 10:1, the injection port temperature was maintained at 200°C, and a hydrogen flame ionization detector was used. S-(+)-ECH was analyzed in detail by this analysis method, and three different batches of samples were measured. The GC system was used for verification.

Results: The method verification results included the system suitability, specificity, sensitivity, accuracy, precision, and the good correlation coefficient between peak responses and concentrations were over 0.990.

Conclusion: The method proposed in this study is the most detailed GC method currently used for the analysis of S-(+)-ECH impurities in (S)-oxiracetam. The proposed method has the advantages of fast, convenience, low cost, etc. It provides a reference method for quality control of genotoxic impurity of (S)-oxiracetam.

Keywords: (S)-oxiracetam, S-(+)-epichlorohydrin, GC, genotoxic impurities analysis, chromatogram, Epichlorohydrin (ECH).

« Previous Next »
Graphical Abstract

[1]
Villardita, C.; Parini, J.; Grioli, S.; Quattropani, M.; Lomeo, C.; Scapagnini, U. Clinical and neuropsychological study with oxiracetam versus placebo in patients with mild to moderate dementia. J. Neural Transm. Suppl., 1987, 24, 293-298.
[PMID: 3479527]
[2]
Villardita, C.; Grioli, S.; Lomeo, C.; Cattaneo, C.; Parini, J. Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia of mild to moderate degree. Neuropsychobiology, 1992, 25(1), 24-28.
[http://dx.doi.org/10.1159/000118805] [PMID: 1603291]
[3]
Rozzini, R.; Zanetti, O.; Bianchetti, A. Treatment of cognitive impairment secondary to degenerative dementia. Effectiveness of oxiracetam therapy. Acta Neurol. (Napoli), 1993, 15(1), 44-52.
[PMID: 8456595]
[4]
Itil, T.M.; Menon, G.N.; Songar, A.; Itil, K.Z. CNS pharmacology and clinical therapeutic effects of oxiracetam. Clin. Neuropharmacol., 1986, 9(Suppl. 3), S70-S72.
[http://dx.doi.org/10.1097/00002826-198609003-00011] [PMID: 3594458]
[5]
Bottini, G.; Vallar, G.; Cappa, S.; Monza, G.C.; Scarpini, E.; Baron, P.; Cheldi, A.; Scarlato, G. Oxiracetam in dementia: A double-blind, placebo-controlled study. Acta Neurol. Scand., 1992, 86(3), 237-241.
[http://dx.doi.org/10.1111/j.1600-0404.1992.tb05077.x] [PMID: 1414239]
[6]
Wang, C.; Dong, H.; Liu, H.; Sun, Z.; Yuan, A.; Wu, J.; Hu, Y. Using HPLC to analyze (S)-oxiracetam and four related substances in the bulk drug of (S)-oxiracetam. J. Pharm. Biomed. Anal., 2020, 180, 113072.
[http://dx.doi.org/10.1016/j.jpba.2019.113072] [PMID: 31891873]
[7]
Williams, K.; Lee, E. Importance of drug enantiomers in clinical pharmacology. Drugs, 1985, 30(4), 333-354.
[http://dx.doi.org/10.2165/00003495-198530040-00003] [PMID: 3905334]
[8]
Li, W.; Liu, H.; Jiang, H.; Wang, C.; Guo, Y.; Sun, Y.; Zhao, X.; Xiong, X.; Zhang, X.; Zhang, K.; Nie, Z.; Pu, X. (S)-Oxiracetam is the active ingredient in oxiracetam that alleviates the cognitive impairment induced by chronic cerebral hypoperfusion in rats. Sci. Rep., 2017, 7(1), 10052.
[http://dx.doi.org/10.1038/s41598-017-10283-4] [PMID: 28855592]
[9]
Sarzanini, C.; Bruzzoniti, M.C.; Mentasti, E. Determination of epichlorohydrin by ion chromatography. J. Chromatogr. A, 2000, 884(1-2), 251-259.
[http://dx.doi.org/10.1016/S0021-9673(00)00252-1] [PMID: 10917444]
[10]
Vali, S.J.; Ganduri, R.B.; Sait, S.S. Estimation of epichlorohydrin content in pharmaceutical drug substances by capillary gas chromatography with flame ionisation detection. J. Chem. Pharm. Res., 2011, 3, 399-392.
[11]
Srám, R.J.; Landa, L.; Samková, I. Effect of occupational exposure to epichlorohydrin on the frequency of chromosome aberrations in peripheral lymphocytes. Mutat. Res. Lett., 1983, 122(1), 59-64.
[http://dx.doi.org/10.1016/0165-7992(83)90143-4]
[12]
Shin, I.S.; Park, N.H.; Lee, J.C.; Kim, K.H.; Moon, C.; Kim, S.H.; Shin, D.H.; Park, S.C.; Kim, H.Y.; Kim, J.C. One-generation reproductive toxicity study of epichlorohydrin in Sprague-Dawley rats. Drug Chem. Toxicol., 2010, 33(3), 291-301.
[http://dx.doi.org/10.3109/01480541003734030] [PMID: 20429810]
[13]
Epichlorohydrin. IARC Monogr. Eval. Carcinog. Risks Hum., 1999, 71(Pt 2), 603-628.
[PMID: 10476464]
[14]
Loda, C.; Bernabe, E.; Nicoletti, A.; Bacchi, S.; Dams, R. Determination of epichlorohydrin in active pharmaceutical ingredients by gas chromatography-mass spectrometry. Org. Process Res. Dev., 2011, 15(6), 1388-1391.
[http://dx.doi.org/10.1021/op200203t]
[15]
Gaca, J.; Wejnerowska, G. Determination of epichlorohydrin in water and sewage samples. Talanta, 2006, 70(5), 1044-1050.
[http://dx.doi.org/10.1016/j.talanta.2006.02.017] [PMID: 18970879]
[16]
Tao, Z.Y.; Chai, X.S.; Wu, S.B. Determination of epichlorohydrin and 1,3-dichloro-2-propanol in synthesis of cationic etherifying reagent by headspace gas chromatography. J. Chromatogr. A, 2011, 1218(37), 6518-6521.
[http://dx.doi.org/10.1016/j.chroma.2011.07.015] [PMID: 21813132]
[17]
Lucentini, L.; Ferretti, E.; Veschetti, E.; Sibio, V.; Citti, G.; Ottaviani, M. Static headspace and purge-and-trap gas chromatography for epichlorohydrin determination in drinking water. Microchem. J., 2005, 80(1), 89-98.
[http://dx.doi.org/10.1016/j.microc.2004.12.003]
[18]
Kafle, A.; Coy, S.L.; Wong, B.M.; Fornace, A.J., Jr; Glick, J.J.; Vouros, P. Understanding gas phase modifier interactions in rapid analysis by differential mobility-tandem mass spectrometry. J. Am. Soc. Mass Spectrom., 2014, 25(7), 1098-1113.
[http://dx.doi.org/10.1007/s13361-013-0808-5] [PMID: 24452298]

Rights & Permissions Print Cite
Article Metrics
14
1
© 2024 Bentham Science Publishers | Privacy Policy